Bladder cancer is a form of cancer that begins in the cells that line the inside of the bladder and typically affects older individuals, though it can occur at any age. Although most forms of bladder cancer are treatable, even early-stage bladder cancers are likely to recur, requiring follow up tests and close monitoring years after treatment.
Common symptoms associated with bladder cancer include:
- A growth in the pelvis near the bladder (pelvic mass)
- Abdominal or back pain
- Blood in urine
- Bone pain or pain in the rectal, anal, or pelvic area
- Frequent or painful urination
- Swelling in the lower legs
- Urinary tract infection
- Weight loss
What Causes Bladder Cancer?
Bladder cancer is most common in white males older than 40 years of age but can develop in any person regardless of sex, race, or age. Although a definitive list of causes has not been determined, there are a number of known contributors to the development of bladder cancer, including:
Actos® and Bladder Cancer
According to the U.S. Food and Drug Adminitration (FDA), a number of prescription drugs containing pioglitazone, the active ingredient in Actos®, have been associated with a 40 percent increase in risk for bladder cancer. If you are a non-smoker and took a prescription medication containing pioglitazone before being diagnosed with bladder cancer, contact us immediately for a free case evaluation. You may be entitled to compensation.
Never stop taking any medication without first consulting your doctor. Actos® is a registered trademark of Takeda Pharmaceutical Company Limited and is used here only for the purpose of identifying the products in question. This law firm is not associated with, sponsored by, or affiliated with the U.S. Food and Drug Administration or Takeda Pharmaceutical Company Limited.
We will not share your information for solicitation purposes. Your information will be received by Ferrer, Poirot & Wansbrough Attorneys at Law.
If you or someone you know was injured by Actos®, contact a lawyer today to get the help you deserve.